143 related articles for article (PubMed ID: 29100024)
21. Triptolide cooperates with chemotherapy to induce apoptosis in acute myeloid leukemia cells.
Pigneux A; Mahon FX; Uhalde M; Jeanneteau M; Lacombe F; Milpied N; Reiffers J; Belloc F
Exp Hematol; 2008 Dec; 36(12):1648-59. PubMed ID: 18922616
[TBL] [Abstract][Full Text] [Related]
22. The simultaneous inhibition of the mTOR and MAPK pathways with Gnetin-C induces apoptosis in acute myeloid leukemia.
Espinoza JL; Elbadry MI; Taniwaki M; Harada K; Trung LQ; Nakagawa N; Takami A; Ishiyama K; Yamauchi T; Takenaka K; Nakao S
Cancer Lett; 2017 Aug; 400():127-136. PubMed ID: 28456658
[TBL] [Abstract][Full Text] [Related]
23. Effect of cloretazine (VNP40101M) on acute myeloid leukaemia blast cells in vitro as a single agent and combined with cytarabine and daunorubicin.
Morris KL; Adams JA; Liu Yin JA
Leuk Res; 2009 Aug; 33(8):1096-9. PubMed ID: 19268363
[TBL] [Abstract][Full Text] [Related]
24. Cytosine arabinoside (ara-C) and cis-dichlorodiammineplatinum II (cisplatin) alone and in combination: effects on acute myeloblastic leukemia blast cells in culture and in vivo.
Wang YF; Curtis JE; Lipton J; Minkin S; McCulloch EA
Leukemia; 1991 Jun; 5(6):522-7. PubMed ID: 1711641
[TBL] [Abstract][Full Text] [Related]
25. SIRT3 deacetylase activity confers chemoresistance in AML via regulation of mitochondrial oxidative phosphorylation.
Ma J; Liu B; Yu D; Zuo Y; Cai R; Yang J; Cheng J
Br J Haematol; 2019 Oct; 187(1):49-64. PubMed ID: 31236919
[TBL] [Abstract][Full Text] [Related]
26. MK-2206 induces apoptosis of AML cells and enhances the cytotoxicity of cytarabine.
Lu JW; Lin YM; Lai YL; Chen CY; Hu CY; Tien HF; Ou DL; Lin LI
Med Oncol; 2015 Jul; 32(7):206. PubMed ID: 26087957
[TBL] [Abstract][Full Text] [Related]
27. Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia.
Eriksson A; Österroos A; Hassan S; Gullbo J; Rickardson L; Jarvius M; Nygren P; Fryknäs M; Höglund M; Larsson R
Blood Cancer J; 2015 Apr; 5(4):e307. PubMed ID: 25885427
[TBL] [Abstract][Full Text] [Related]
28. Curcumin sensitizes response to cytarabine in acute myeloid leukemia by regulating intestinal microbiota.
Liu J; Luo W; Chen Q; Chen X; Zhou G; Sun H
Cancer Chemother Pharmacol; 2022 Feb; 89(2):243-253. PubMed ID: 35066694
[TBL] [Abstract][Full Text] [Related]
29. Azacitidine and low-dose cytarabine in palliative patients with acute myeloid leukemia and high bone marrow blast counts--a retrospective single-center experience.
Radujkovic A; Dietrich S; Bochtler T; Krämer A; Schöning T; Ho AD; Dreger P; Luft T
Eur J Haematol; 2014 Aug; 93(2):112-7. PubMed ID: 24628527
[TBL] [Abstract][Full Text] [Related]
30. Apatinib enhances chemosensitivity of acute myeloid leukemia hl60 cells to cytarabine by inducing apoptosis.
Pan Q; Wang J; Jiang X; Yang E; Dong L; Gu K
J BUON; 2019; 24(1):374-381. PubMed ID: 30941994
[TBL] [Abstract][Full Text] [Related]
31. Voreloxin, a first-in-class anticancer quinolone derivative, acts synergistically with cytarabine in vitro and induces bone marrow aplasia in vivo.
Scatena CD; Kumer JL; Arbitrario JP; Howlett AR; Hawtin RE; Fox JA; Silverman JA
Cancer Chemother Pharmacol; 2010 Oct; 66(5):881-8. PubMed ID: 20058009
[TBL] [Abstract][Full Text] [Related]
32. Mebendazole exhibits potent anti-leukemia activity on acute myeloid leukemia.
He L; Shi L; Du Z; Huang H; Gong R; Ma L; Chen L; Gao S; Lyu J; Gu H
Exp Cell Res; 2018 Aug; 369(1):61-68. PubMed ID: 29750898
[TBL] [Abstract][Full Text] [Related]
33. l-Asparaginase-mediated downregulation of c-Myc promotes 1,25(OH)
Song JH; Park E; Kim MS; Cho KM; Park SH; Lee A; Song J; Kim HJ; Koh JT; Kim TS
Int J Cancer; 2017 May; 140(10):2364-2374. PubMed ID: 28224619
[TBL] [Abstract][Full Text] [Related]
34. Synergisitic and Antagonistic AML Cell Type-specific Responses to 5-Aza-2-deoxycitidine and 1-h-D-Arabinofuranoside.
Elmoneim AA; Heuston E; Wai DH; Triche T; Arceci RJ
Anticancer Res; 2016 Feb; 36(2):691-6. PubMed ID: 26851026
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of the cytotoxic effects of Cytarabine in synergism with Hesperidine and Silibinin in Acute Myeloid Leukemia: An in-vitro approach.
Desai UN; Shah KP; Mirza SH; Panchal DK; Parikh SK; Rawal RM
J Cancer Res Ther; 2015; 11(2):352-7. PubMed ID: 26148599
[TBL] [Abstract][Full Text] [Related]
36. A novel alkylating deacetylase inhibitor molecule EDO-S101 in combination with cytarabine synergistically enhances apoptosis of acute myeloid leukemia cells.
Jin J; Mao S; Li F; Li X; Huang X; Yu M; Guo W; Jin J
Med Oncol; 2019 Aug; 36(9):77. PubMed ID: 31372848
[TBL] [Abstract][Full Text] [Related]
37. Selective Inhibitors of Histone Deacetylases 1 and 2 Synergize with Azacitidine in Acute Myeloid Leukemia.
Min C; Moore N; Shearstone JR; Quayle SN; Huang P; van Duzer JH; Jarpe MB; Jones SS; Yang M
PLoS One; 2017; 12(1):e0169128. PubMed ID: 28060870
[TBL] [Abstract][Full Text] [Related]
38. Rapamycin increases leukemia cell sensitivity to chemotherapy by regulating mTORC1 pathway-mediated apoptosis and autophagy.
Xu J; Zong S; Sheng T; Zheng J; Wu Q; Wang Q; Tang A; Song Y; Fei Y; Li Z
Int J Hematol; 2024 May; 119(5):541-551. PubMed ID: 38530586
[TBL] [Abstract][Full Text] [Related]
39. Additive effect of PTK787/ZK 222584, a potent inhibitor of VEGFR phosphorylation, with Idarubicin in the treatment of acute myeloid leukemia.
Barbarroja N; Torres LA; Luque MJ; Carretero RM; Valverde-Estepa A; Lopez-Sanchez LM; Rodriguez-Ariza A; Velasco F; Torres A; López-Pedrera C
Exp Hematol; 2009 Jun; 37(6):679-91. PubMed ID: 19463770
[TBL] [Abstract][Full Text] [Related]
40. The effects of cytarabine combined with ginsenoside compound K synergistically induce DNA damage in acute myeloid leukemia cells.
Qi W; Yan X; Xu X; Song B; Sun L; Zhao D; Sun L
Biomed Pharmacother; 2020 Dec; 132():110812. PubMed ID: 33059263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
